Amanda Nerstad: This is hope

Amanda Nerstad, Lung cancer survivor and advocate, shared on X:

“This is hope. Patient #2 in the Peptide vaccine ALK plus NSCLC clinical trial!

We are hopeful this groundbreaking vaccine will turn this terminal disease into a chronic one. I believe in my doctor as much as he believes in me.”

Yvonne Diaz, Co-founder at Oncogene Cancer Research, replied:

“This is what hope and research look like. Thank you Amanda Nerstad, for supporting this research by Dr Vincent Lam into an ALK+ cancer vaccine.

Appreciate all the patients who participate in clinical trials improving our survival and care.”

Source: Amanda Nerstad/X and Yvonne Diaz/X